Word

RAXONE

Status

Registered

Status Code

700

Status Date

Tuesday, September 26, 2023

Serial Number

97407005

Registration Number

7172934

Registration Date

Tuesday, September 26, 2023

Mark Type

4000

Filing Date

Thursday, May 12, 2022

Published for Opposition

Tuesday, July 11, 2023

Trademark Owner History

CHIESI FARMACEUTICI S.P.A. -
Santhera Pharmaceuticals (Schweiz) AG - Original Registrant

Classifications

5 pharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss

1 chemicals used in industry and science

42 computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss

Trademark Events

Oct 4, 2023

Automatic Update Of Assignment Of Ownership

Sep 26, 2023

Notice Of Registration Confirmation Emailed

Sep 26, 2023

Registered-Principal Register

Jul 11, 2023

Official Gazette Publication Confirmation E-Mailed

Jul 11, 2023

Published For Opposition

Jun 21, 2023

Notification Of Notice Of Publication E-Mailed

Jun 2, 2023

Law Office Publication Review Completed

May 26, 2023

Approved For Pub - Principal Register

May 24, 2023

Teas/Email Correspondence Entered

May 24, 2023

Correspondence Received In Law Office

May 24, 2023

Teas Response To Office Action Received

Mar 2, 2023

Notification Of Non-Final Action E-Mailed

Mar 2, 2023

Non-Final Action E-Mailed

Mar 2, 2023

Non-Final Action Written

Mar 2, 2023

Assigned To Examiner

Jun 30, 2022

Preliminary/Voluntary Amendment - Entered

Jun 30, 2022

Assigned To Lie

May 17, 2022

Teas Voluntary Amendment Received

May 17, 2022

New Application Office Supplied Data Entered

May 16, 2022

New Application Entered